NovoCure Ltd — Director's Dealing 2020

Apr 15, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2020-04-13

Reporting Person: Ambrogi Michael J. (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-04-13	Ordinary Shares	M	22755	$7.15	Acquired	243622	Direct
2020-04-13	Ordinary Shares	S	22755	$69.008	Disposed	220867	Direct
2020-04-14	Ordinary Shares	M	35745	$7.15	Acquired	256612	Direct
2020-04-13	Ordinary Shares	S	8226	$70.182	Disposed	248386	Direct
2020-04-14	Ordinary Shares	S	27142	$70.994	Disposed	221244	Direct
2020-04-14	Ordinary Shares	S	377	$71.753	Disposed	220867	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-04-13	Options to Buy Ordinary Shares	$7.15	M	22755	Disposed	2027-02-21	Ordinary Shares (22755.0)	Direct
2020-04-14	Options to Buy Ordinary Shares	$7.15	M	35745	Disposed	2027-02-21	Ordinary Shares (35745.0)	Direct

Footnotes

F1: On April 13, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 22,755 shares in multiple trades at prices ranging from $69.00 to $69.42. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.

F2: On April 14, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 8,226 shares in multiple trades at prices ranging from $69.62 to $70.61. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.

F3: On April 14, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 27,142 shares in multiple trades at prices ranging from $70.62 to $71.51. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.

F4: On April 14, 2020, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Ambrogi, Mr. Ambrogi sold 377 shares in multiple trades at prices ranging from $71.64 to $71.88. The price reported above reflects the weighted average sale price. Mr. Ambrogi hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer upon request, full information regarding the number of shares and prices at which the transaction was effected.

F5: Fully vested as of the date hereof.